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In vitro effects of some drugs on human erythrocyte
glutathione reductase
Ebru AKKEMİK1, Murat ŞENTÜRK2, Fatma Betül ÖZGERİŞ3, Pınar TAŞER, Mehmet ÇİFTCİ1

Aim: The effects of dacarbazine, thiocolchicoside, methotrexate, olanzapine, pantoprazole sodium, and 5-fluorouracil
on the enzyme activity of glutathione reductase (GR) were studied using human erythrocyte GR enzymes in in vitro
studies, respectively.
Materials and methods: The enzyme was purified 3333-fold from human erythrocytes in a yield of 44.44% with 4.0
U/mg. The purification procedure involved the preparation of hemolysate, ammonium sulfate precipitation, 2’, 5’-ADP
Sepharose 4B affinity chromatography, and Sephadex G-200 gel filtration chromatography. SDS-PAGE showed a single
band for enzyme. Purified enzyme was used in the in vitro studies.
Results: In the in vitro studies, IC50 values and Ki constants were 0.014 mM and 0.0121 ± 0.0026 mM for dacarbazine,
and 0.054 mM and 0.0135 ± 0.0024 mM for thiocolchicoside, 0.31 mM and 0.1213 ± 0.040 mM for methotrexate, 0.35
mM and 0.3173 ± 0.0981 mM for olanzapine, 0.94 mM and 0.5413 ± 0.0728 mM for pantoprazole sodium, and 98.57 mM
and 69.611 ± 9.690 mM for 5-fluorouracil, showing the inhibition effects on the purified enzyme. Inhibition types were
non-competitive for dacarbazine, methotrexate, olanzapine, and 5-fluorouracil and competitive for thiocolchicoside
and pantoprazole sodium.
Conclusion: All the drugs indicated the inhibitory effects on the enzyme.
Key words: Glutathione reductase, dacarbazine, thiocolchicoside, methotrexate

Bazı ilaçların insan eritrosit glutatyon redüktaz enzimi üzerine etkileri
Amaç: Bu çalışmada dekarbazin, tiyokolsikosid, metotreksat, olanzapin, sodium pantoprozol ve 5-florourasil ilaçlarının
insan eritrositlerinden saflaştırılan glutatyon redüktaz enzimi (GR) üzerine in vitro etkileri araştırıldı.
Yöntem ve gereç: Bu amaçla 4 EÜ/mg protein spesifik aktivitesine sahip olan enzim sırasıyla hemolizatın hazırlanması,
amonyum sülfat çöktürmesi, Sephadex G-200 jel filtrasyon kromatografisi ve 2’,5’-ADP Sepharose 4B afinite
kromatografisi ile % 44,44 verimle 3333 kat saflaştırıldı. Bu dört basamak sonucu elde edilen saf enzimin saflık kontrolü
sodyum dodesilsülfat poliakrilamid jel elektroforezzi (SDS-PAGE) ile yapıldı. Tüm kinetik çalışmalarda saflaştırılmış
enzim kullanıldı.
Bulgular: Enzim üzerinde inhibisyon etkisi gösteren dekarbazin, tiyokolsikosid, metotreksat, olanzapin, sodium
pantoprozol ve 5-florourasil ilaçları için sırasıyla IC50 değerleri ve Ki sabitleri 0,014 ve 0,0121 ± 0,0026; 0,054 ve 0,0135
± 0,0024; 0,31 ve 0,1213 ± 0,040; 0,35 mM ve 0,3173 ± 0,0981; 0,94 ve 0,5413 ± 0,0728; 98,57 ve 69,611 ± 9,690; olarak
hesaplandı. Ayrıca inhibisyon çeşidi çalışmaları sonucu tüm ilaçların enzimi yarışmasız olarak inhibe ettikleri tespit
edildi.
Sonuç: Kullanılan tüm ilaçların enzim üzerinde inhibisyon etkisi tespit edildi.
Anahtar sözcükler: Glutatyon redüktaz, dekarbazin, tiyokolsikosid, metotreksat
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Introduction
Glutathione
(γ-L-glutamyl-L-cysteinylglycine;
GSH) has many important functions. It is an
antioxidant, is involved in the detoxification of
xenobiotics, and serves as a cofactor in isomerization
reactions (1). Glutathione has an important role in
the synthesis and degradation of proteins, regulation
of enzymes, formation of the deoxyribonucleotid
precursors of deoxyribonucleic acid (DNA) and
protection of cells against free radicals and reactive
oxygen species (2). Responsible for the reduction of
GSSG to GSH is the enzyme glutathione reductase (GR;
NADPH: oxidized glutathione oxidoreductase, EC
1.6.4.2), a flavoprotein which uses NADPH as electron
donor for the reduction reaction. GR enables several
vital functions of the cell, such as the detoxification
of free radicals and reactive oxygen species as well as
protein and DNA biosynthesis, by maintaining a high
ratio of GSH/GSSG (3). Decreased glutathione levels
have also been reported in several diseases, such as
acquired immune deficiency syndrome (AIDS) (4),
Parkinson’s disease (5), and diabetes (6,7). A major
role of GSH in erythrocytes is the prevention of
hemoglobin denaturation, preserving the integrity
of erythrocyte membrane sulfhydryl groups and
detoxification of the xenobiotics and reactive oxygen
species in red blood cells (8).

Materials and methods
Materials
2’, 5’-ADP Sepharose 4B was purchased from
Pharmacia. Sephadex G-200, NADPH, GSSG,
the protein assay reagent and the chemicals for
electrophoresis were purchased from Sigma Chem.
Co. (Germany). All other chemicals used were
analytical grade and purchased from either Merck or
Sigma (Germany).
Preparation of the hemolysate
Fresh human blood from one single subject was
collected into a tube containing 0.1 M Na-citrate,
0.16 M glucose, 0.016 M Na-phosphate, and 2.59
mM adenine for anticoagulation. The sample was
centrifuged at 3000 × g for 15 min. Plasma and
leukocyte coat were removed. The erythrocytes were
washed three times with isotonic NaCl solution
including 1 mM EDTA, the samples being centrifuged
at 3000 × g each time and the supernatants removed.
The washed erythrocytes were hemolyzed with 5
volumes of ice-cold distilled water containing 2.7
mM EDTA and 0.7 mM β-mercaptoethanol, and
then centrifuged at 4 °C, 20,000 × g for 30 min to
remove residual intact cells and membranes (16).
Ammonium sulfate fractionation and dialysis

Many drugs have activation or inhibition effects on
the body’s enzyme systems (9-11). Many drugs may
show the same effects under both in vivo and in vitro
conditions; however, some of them may not show the
same effects on enzymes (12-14). Both fluorouracil
(5-FU) and dacarbazine are used for treatments of
some different cancer diseases. Methotrexate is used
in cancer chemotherapy. Contrary to these 3 drugs,
thiocolchicoside is used for symptomatic treatment
of painful muscle spasms; and while pantoprazole
sodium is a proton pump inhibitor drug used for
short-term treatment of erosion and ulceration of the
esophagus caused by gastroesophageal reflux disease
olanzapine is a novel antipsychotic agent (15).

The hemolysate was subjected to precipitation with
ammonium sulfate (between 30% and 70%). Enzyme
activity was determined both in the supernatant and
in the precipitate for each respective precipitation.
The precipitate was dissolved in phosphate buffer (50
mM, pH 7.0). The resultant solution was clear, and
contained partially purified enzyme. This solution
was dialyzed at 4 °C in 1 mM EDTA + 10 mM
K-phosphate buffer (pH 7.5) for 2 h with 2 changes
of buffer (12). Partially purified enzyme solution was
kept at 4 °C.

We have not encountered any studies on the effects
of dacarbazine, thiocolchicoside, methotrexate,
olanzapine, pantoprazole sodium, and 5-fluorouracil
on human erythrocyte GR activity. The objective
of the present study was to investigate any possible
in vitro effects of these drugs on purified human
erythrocyte GR.

Dry 2’, 5’-ADP Sepharose 4B (2 g) was washed
and swelled in distilled and deionized water. After
removal of the air in the gel, it was resuspended in
0.1 M Kacetate/0.1 M K-phosphate buffer, pH 6.0,
and packed into a small column (1 × 10 cm). After
precipitation of the gel, it was equilibrated with the
same buffer by means of a peristaltic pump with the
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flow rate adjusted to 20 mL/h. The dialyzed sample
obtained from ammonium sulfate precipitation was
loaded onto the column, and washed with 25 mL
of 0.1 M K-acetate + 0.1 M K-phosphate, pH 6.0
and 25 mL of 0.1 M Kacetate + 0.1 M K-phosphate,
pH 7.85. Washing continued with 50 mM of
K-phosphate including 1 mM EDTA (pH 7.0) until
the final absorbance difference was 0.05 at 280 nm.
Proteins bound on the gel were eluted with a gradient
of 0-0.5 mMGSH and 0-1m M NADPH in 50 mM
K-phosphate, containing 1 mM EDTA (pH 7.0).
Active fractions were collected and dialyzed with 50
mM of K-phosphate including 1 mM EDTA (pH 7.0)
at 4 °C (17-20).
Sephadex G-200 gel filtration chromatography
Dry Sephadex G-200 (5 g) was incubated in
distilled water at 90 °C for 5 h. After removal of the
air in the gel, it was loaded onto a column (2 × 50
cm). The flow rate was adjusted to 15 mL/h by means
of a peristaltic pump. The column was equilibrated
with 50 mM Tris-HCl, and 50 mM KCl buffer (pH
7.0) until the final absorbance difference became 0
at 280 nm and the pH was the same as that of the
equilibration buffer. The dialyzate from the affinity
chromatography column was mixed with glycerol in
a proportion of 5%. The final sample was loaded onto
the column and 2 mL of each elution was collected.
The absorbance values were determined at 280 nm
and 340 nm in each fraction (11). Active fractions
were lyophilized and stored at -85 °C for use in the
in vitro studies.

Shimadzu Spectrophotometer UV-(1208) at 25 °C.
The assay system contained 40 mM Tris-HCl buffer,
pH 8.0, including 0.8 mM EDTA, 1 mM GSSG, and
0.1 mM NADPH in 1 mL total reaction volume. The
activity was measured by monitoring the decrease
in absorbance at 340 nm due to the oxidation of
NADPH at 25 °C. One enzyme unit is defined as the
oxidation of 1 μmol NADPH per min under the assay
conditions.
Protein determination
Quantitative protein determination was performed
spectrophotometrically at 595 nm according to
Bradford’s method (23), using bovine serum albumin
as a standard. Qualitative protein determination was
also performed spectrophotometrically at 280 nm
according to Segel’s method (24).
In vitro drug studies
Dacarbazine, thiocolchicoside, methotrexate,
olanzapine, pantoprazole sodium, and 5-fluorouracil
tested to determine their effects on human
erythrocyte GR activity. Assays were performed
in cuvette concentrations of 0.004-0.053 mM
dacarbazine, 0.035-0.14 mM thiocolchicoside, 0.0221.1 mM methotrexate, 0.16-0.96 mM olanzapine,
0.24-1.96 mM pantoprazole sodium, and 19.22-

Sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE)
To determine the enzyme’s purity, SDS-PAGE
was performed according to Laemmli’s method (21).
The acrylamide concentration of the stacking and
separating gels was 3% and 8%, respectively, and
1% SDS was also added to the gel solution. The gel
was stained for 2 h in 0.1% Coomassie Brilliant Blue
R-250 containing 50% methanol, 10% acetic acid
and 40% distilled water. Then the gel was washed
with many changes of the same solvent without dye.
Cleared protein bands were photographed (Figure 1).
Activity assay
Glutathione reductase activity was determined by
the method of Carlberg and Mannervik (22) with a

Figure 1. SDS-PAGE photograph: Lane 1, purified enzyme
from Sephadex G-200 gel filtration. Lane 2, standard
proteins: rabbit myosin (205 kDa), bovine carbonic
anhydrase-I (29 kDa), egg albumin B (45 kDa), bovine
albumin (66 kDa).
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192.28 mM 5-fluorouracil. The enzyme activity in the
absence of drug was used as a control (100% activity).
The IC50 values were obtained from activity (%) vs.
drug concentration plots and regression analysis
graphs were drawn by a statistical package (SPSS for
Windows; version 10.0) (Student’s t-test; n = 3). In
order to determine Ki constants for the inhibitors,
the substrate (GSSG) concentrations were 0.03, 0.08,
0.14, 0.2, and 0.3 mM. Inhibitors (drugs) solutions
were added to the reaction medium, at 3 different
fixed concentrations of inhibitors in 1 mL of total
reaction volume. Lineweaver-Burk graphs (25) were
drawn by using 1/V vs. 1/[S] values and Ki constant
were calculated from these graphs.
Results
The purification of the enzyme led to a specific
activity of 4 EU/mg protein, a yield of 44.44% and a
purification coefficient of 3333. SDS polyacrylamide
gel electrophoresis was performed after the
purification of the enzyme, and the electrophoretic
pattern was photographed (Figure 1). IC50 values
of dacarbazine, thiocolchicoside, methotrexate,
olanzapine, pantoprazole sodium, and 5-fluorouracil
were 0.014, 0.054, 0.31, 0.35, 0.94, and 98.57 mM,
respectively, and the Ki constants were 0.0121 ±
0.0026, 0.0135 ± 0.0024, 0.1213 ± 0.040, 0.3173 ±
0.0981, 0.5413 ± 0.0728, and 69.611 ± 9.690 mM
respectively (Table). Representative graphs are shown
for dacarbazine (Figures 2 and 3). Inhibition types
were non-competitive for dacarbazine, methotrexate,
olanzapine, and 5-fluorouracil and competitive for
thiocolchicoside and pantoprazole sodium.

Discussion
Enzymatic defense is provided by many enzyme
systems such as glutathione reductase, glutathione
peroxidase, glutathione S transferase (GST),
superoxide dismutase, catalase, aldoketoreductase,
and DNA repair enzymes (25). Glutathione
reductase catalyzes the reduction of GSSG in the
presence of NADPH, with the latter being produced
in the pentose phosphate metabolic pathway. GSH
is a product of the reaction catalyzed by glutathione
reductase, and the GSH-related enzyme system is
one of the most important protective systems in cells.
Reduced glutathione is used in the detoxification
of xenobiotics, protection of the thiol groups of
intracellular proteins, scavenging of H2O2 and other
organic peroxides, and counteraction of oxidative
events. The first step, in the detoxification of
xenobiotics, consists of GSH conjugates owing to its
high nucleophilic potency (27).
Many chemicals and drugs are known to have
adverse or beneficial effects on human enzyme
and metabolic events, and the effects can be
dramatic and systemic (28). The inhibition of some
important enzymes plays a key role in a metabolic
pathway, e.g. some metabolic diseases are affected
by enzyme activity (29). Similarly, acetazolamide
has an inhibitory effect on the carbonic anhydrase
(CA) enzyme leading to diuresis (30). Additionally,
epiandrosterone was found to inhibit red
blood cell glucose 6-phosphate dehydrogenase
(G6PD) uncompetitively and suppress hexose
monophosphate shunt activity by more than 95% (31).
Some chemicals and drugs, such as nitrofurazone,

Table. Ki constants and IC50 values obtained from regression analysis graphs for GR in the
presence of different drugs.
Drugs
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IC50 (mM)

Ki (mM)

Inhibition type

Dacarbazine

0.014

0.0121 ± 0.0026

Non-competitive

Thiocolchicoside

0.054

0.0135 ± 0.0024

Competitive

Methotrexate

0.310

0.1213 ± 0.0400

Non-competitive

Olanzapine

0.350

0.3173 ± 0.0981

Non-competitive

Pantoprazole Sodium

0.940

0.5413 ± 0.0728

Competitive

5-Fluorouracil

98.57

69.611 ± 9.6900

Non-competitive
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a likely consequence of glyoxalase I inhibition (41).
When methotrexat was used as a chemotherapy
drug, it was seen that ALT rises 14% and AST rises
8%. After the drug is discontinued enzymes turn to
normal (42).

100
y = 100e -49,771x

Activity %

80
60
40
20
0
0

0.01

0.02

0.03

0.04

0.05

[Dacarbazine] mM

Figure 2. Activity % vs [Dacarbazine] regression analysis graphs
for human erythrocytes GR in the presence of 5
different dacarbazine concentrations.

600

Control
0.0026 mM
0.013 mM
0.027 mM

1/ V

400

200

-5

0

5

15

25

1/[GSSG] mM

Figure 3. Lineweaver-Burk graph with 5 different substrate
(GSSG) concentrations and 3 different dacarbazine
concentrations for determination of Ki.

nitrofurantoin, 5-nitroindol, 5-nitro-2-furoic acid,
2, 4, 6-trinitrobenzene sulfonate (TNBS) (32), and
polyphenolic compounds, also inhibit GR enzyme
activity (32). Furthermore, it is reported that human
erythrocyte GR, human erythrocyte CA-I and CAII, human erythrocyte G6PD and human erythrocyte
6PGD are inhibited by some drugs and chemicals
(11-14,34-39).
Dacarbazine can induce a marked reduction of
blast cells as well as severe myelotoxicity in leukemic
patients (40). Methotrexat inhibits the metabolism
of a-oxoaldehydes in vivo in leukemic children, as

In the present paper, the effects of some commonly
used drugs on human erythrocyte GR enzyme were
investigated. In order to show inhibitory effects,
while the most suitable parameter is the Ki constant,
some researchers use the IC50 value. Therefore, in this
study, both the Ki and IC50 parameters of these drugs
for GR were determined.
IC50 values of dacarbazine, thiocolchicoside,
methotrexate, olanzapine, pantoprazole sodium, and
5-fluorouracil were 0.014, 0.054, 0.31, 0.35, 0.94, and
98.57 mM, and the Ki constants were 0.0121 ± 0.0026,
0.0135 ± 0.0024, 0.1213 ± 0.040, 0.3173 ± 0.0981,
0.5413 ± 0.0728, and 69.611 ± 9.690 mM, respectively.
Ki constants show that dacarbazine had the highest
inhibitory effect, followed by thiocolchicoside,
methotrexate, olanzapine, pantoprazole sodium, and
5-fluorouracil, in that order. IC50 values showed the
same trend. In this investigation, by using the obtained
Ki constants and IC50 values, undesirable side effects
of these drugs on GR activity and body metabolism
and antioxidative capacity can be reduced.
The Table shows that the enzyme is mostly
inhibited
by dacarbazine,
thiocolchicoside,
methotrexate, olanzapine, and pantoprazole sodium
drugs. The chemical structures of all these drugs
contain an active group of carbonyl and nitrogen.
Only olanzapine does not contain a carbonyl group.
Moreover, thiocolchicoside and olanzapine contain
sulfur groups and methotrexate contains hydroxyl
groups. 5-Fluorouracil, which has a less inhibitory
effect on the enzyme’s activity, contains carbonyl,
fluoride, and nitrogen groups, but does not contain
sulfur and hydroxyl groups.
The dosages of the examined drugs (iv) used
clinically give blood drug concentrations as follows;
dacarbazine ~4, thiocolchicoside ~58, methotrexate
~315, olanzapine ~455, pantoprazole sodium ~345,
and 5-fluorouracil ~532 mM (19). By taking into
account these concentrations, the inhibition data
calculated from plots were found to be 2%, 13%, 23%,
1%, 0.4%, 0%, and 0.1%, respectively. According
to these data, if patients are required to be given
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thiocolchicoside and methotrexate, their dosage
should be very well controlled to decrease hemolytic
and other side effects due to possible inhibition of
GR.

Acknowledgment
This research was financed by grants from the
Scientific and Technological Research Council of
Turkey (TÜBİTAK) (Project No: 108T213).

References
1.

Meisler A, Anderson ME. Glutathione. Ann Rev Biochem 1983;
52: 711-760.

2.

Gul M, Kutay FZ, Temocin S, Hanninen O. Cellular and clinical
implications of glutathione. Indian J Exp Biol 2000; 38: 625634.

3.

Schirmer RH, Krauth-Siegel RL, Schulz GE. Glutathione
reductase. New York, John Wiley and Sons Press 1989; 553559.

4.

Akerlund B, Tynell E, Bratt G, Bielentein M, Lidman C.
Nacetylcysteine treatment and the risk of toxic reactions to
trimethoprimsulphamethoxazole in primary Pneumocystis
carini prophylaxis in HIV infected patients. J Infect 1997; 35:
143-147.

5.

Jenner P. Olanow CW. Understanding cell death in Parkinson’s
disease. Ann Neurol 1998; 44: 72-84.

6.

Yoshida K. Hirokawa J. Tagami S, Kawakami Y, Urata Y, Kondo
T. Weakened cellular scavenging activity against oxidative
stress in diabetes mellitus: Regulation of glutathione synthesis
and efflux. Diabetologia 1995; 38: 201-210.

7.

Vijayalingam S, Parthiban A, Shanmugasundaram KR, Mohan
V. Abnormal antioxidant status in impaired glucose tolerance
and non-insulindependent diabetes mellitus. Diabet Med
1996; 13: 715-719.

8.

9.

Srivastava S.K, Beutler E. Glutathione metabolism of the
erythrocyte. The enzymic clevage of glutathione-haemoglobin
preparations by glutathione reductase. Biochem J 1970; 119:
353-357.
Edward E, Morse MD. Toxic effects of drugs on erythrocytes.
Ann Clin Sci 1988; 18: 13-18.

10. Jacobasch G, Rapoport SM. Hemolytic anemias due to
erythrocyte enzyme deficiencies. Mol Aspects Med 1996; 17:
143-170.
11. Erat M, Sakiroglu H, Ciftci M. Effects of some antibiotics on
glutathione reductase from bovine erythrocytes. Vet Med
Czech 2003; 48: 305-312.

14. Erat M, Ciftci M. In vitro effects of some antibiotics on
glutathione reductase from sheep liver. J Enz Inhib Med Chem
2003; 18: 545-550.
15. Beutler E. Red Cell Metabolism. A manual of biochemical
methods. Orlando: Grune and Stratton Inc. 1984; p 134-135.
16. Kayaalp SO. Rasyonal tedavi yönünden tıbbi farmakoloji
Hacettepe-Tas Yayıncılık, Ankara. 1998. (book in Turkish).
17. Erat M, Sakiroglu H, Ciftci M. Purification and characterization
of glutathione reductase from bovine erythrocytes. Prep
Biochem Biotechn 2003; 33: 283-299.
18. Boggaram V, Brobjer T, Larson K, Mannervik B. Purification
of glutathione reductase from porcine erythrocytes by the use
of affinity chromatography on 2’, 5’-ADPSepharose 4B and
crystallization of the enzyme. Anal Biochem 1979; 98: 335-340.
19. Carlberg I, Mannervik B. Purification and characterization
glutathione reductase from calf liver. An improved procedure
for affinity chromatography on 2’, 5’-ADP Sepharose 4B. Anal
Biochem 1981; 116: 531-536.
20. Trang NL, Bhargava KK, Cerami A. Purification of glutathione
reductase from gerbil liver in two steps. Anal Biochem 1983;
133: 94-99.
21. Laemmli UK. Cleavage of structural proteins during the
assembly of the head of bacteriophage T4. Nature, 1970; 227:
680-685.

22. Carlberg I, Mannervik B. Methods Enzymol 1985; 113: 484495, Academic Press, Orlando FL.
23. Bradford MM. A rapid and sensitive method for the quantitation
(quantification**) of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem 1976; 72:
248-251.
24. Segel IH. Biochemical calculation. New York: Inc. 1968. 403.
25. Lineweaver H, Burk D. The determination of enzyme
dissocation constants. J Am Chem Soc 1934; 56: 658-666.

12. Erat M, Ciftci M. Effect of melatonin on enzyme activities of
glutathione reductase from human erythrocytes in vitro and
from rat erythrocytes in vivo. Eur J Pharmacol 2006; 537: 5963.

26. Meister A. Glutathione metabolism and its selective
modification. J Biol Chem 1988; 263: 17205-17208.

13. Erat M, Sakiroglu H, Ciftci M. Effects of some antibiotics on
glutathione reductase activities from human erythrocytes in
vitro and from rat erythrocytes in vivo. J Enz Inhib Med Chem
2005; 20: 69-74.

28. Christensen GM, Olson D, Riedel B. Chemical effects on the
activity of eight enzymes: a review and discussion relevant to
environmental monitoring. Environ Res 1982; 29: 247-255.

240

27. Beckett GJ, Hayes JD. Glutathione S-transferases: biomedical
applications. Adv. Clin. Chem, 1993; 30: 281-380.

E. AKKEMİK, M. ŞENTÜRK, F. B. ÖZGERİŞ, P. TAŞER, M. ÇİFTCİ

29. Gupta BL, Nehal M, Baquer NZ. Effect of experimental
diabetes on the activities of hexokinase, glucose-6-phosphate
dehydrogenase, and catecholamines in rat erythrocytes of
different agents. Indian J Exp Biol 1997; 35: 792-795.
30. Warnock DG. Diuretic agent. In: Katzung BG, editor. Basic, and
clinical pharmacology, 4th ed., USA: Appleton and Lange; 1989.
p 183.
31. Grossman S, Budinsky R, Jollow D. Dapsone-induced hemolytic
anemia: role of glucose-6-phosphate dehydrogenase in the
hemolytic response of rat erythrocytes to N-hydroxydapsone.J
Pharmacol Exp Ther 1995; 273: 870-877.
32. McCallum MJ, Barrett J. The purification and properties of
glutathione reductase from the cestode Moniezia expansa. Int J
Biochem Cell Biol 1995; 27: 393-401.
33. Zhang K, Yang EB, Tang WY, Wong KP, Marck P. Inhibition
of glutathione reductase by plant polyphenols. Biochem
Pharmacol 1997; 54: 1047-1053.
34. Beydemir S, Ciftci M, Ozmen I, Okuroglu ME, Ozdemir H,
Kufrevioglu OI. Effects of some medical drugs on enzyme
activities of carbonic anhydrase from human erythrocytes in
vitro and from rat erythrocytes in vivo. Pharmacol Res 2000;
42: 187-191.
35. Altıkat S, Çiftçi M, Büyükokuroğlu ME. In vitro effects of
some anesthetic drugs on human red blood cell glucose
6-phosphate dehydrogenase enzyme activity. Polish Journal of
Pharmacology 2002; 54: 67-71.

36. Tekman B, Ozdemir H, Senturk M, Ciftci M. Purification and
characterization of glutathione reductase from rainbow trout
(Oncorhynchus mykiss) liver and inhibition effects of metal
ions on enzyme activity. Comparative Biochemistry and
Physiology Part C 2008; 148: 117-121.
37. Senturk M, Gulcin I, Ciftci M, Kufrevioglu OI. Dantrolene
inhibits human erythrocyte glutathione reductase. Biol Pharm
Bull 2008; 31: 2036-2039.
38. Adem S, Ciftci M. Effects of some drugs on human erythrocyte
6-phosphogluconate dehydrogenase: an in vitro study. Journal
of Enzyme Inhibition and Medicinal Chemistry 2007; 22: 751754.
39. Ozdemir H, Ciftci M. In vitro effects of some drugs on
human red blood cell glucose-6-phosphate dehydrogenase
enzyme activity. Journal of Enzyme Inhibition and Medicinal
Chemistry 2006; 21: 75-80.
40. Franchi A, Papa G, Datri S, Piccioni D, Masi M, Bonmassar
E. Cytotoxic effects of dacarbazine in patients with acute
myelogenous leukemia - a pilot-study. Haematologica 1992;
77: 146-50.
41. Katalin B, Sandor T, Ferenc O, Eszter K. Methotrexate inhibits
the glyoxalase system in vivo in children with acute lymphoid
leukaemia. European Journal of Cancer 2004; 40: 2287-2292.
42. http://www.saglikdanis.com/hastalikgoster.asp?hid=774

241

